Hemostats Market Share

  • Report ID: 4484
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Hemostats Market Regional Analysis:

North American Market Insights

The North America hemostats market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035, owing to the region's early adoption of a variety of technologically cutting-edge medical products and solutions as well as the rise in demand for dependable hemostat solutions. Additionally, the prevalence of chronic diseases is increasing in the area, which is fueling market expansion in North America. As per the data of the Centers for Disease Control and Prevention, in the United States, every 4 in 10 persons is suffering from more than 1 chronic problem and around 6 in 10 adults have at least 1 in one chronic issue. Furthermore, the rising need for blood donation and blood transfusion is expected to boost the market growth in the region. In America, more than 4 million people are expected to require blood transfusion every year and in the combined region of the United States and Canada, around 43,000 pints of blood are donated each day.

Hemostats Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of hemostats is evaluated at USD 3.18 Billion.

The global hemostats market size exceeded USD 3 Billion in 2025 and is set to expand at a CAGR of over 6.6%, surpassing USD 5.68 Billion revenue by 2035.

The North America hemostats market will secure around 44.6% share by 2035, driven by early adoption of advanced medical products and rising demand for hemostat solutions.

Key players in the market include Pfizer Inc., Integra LifeSciences Corporation, Baxter, Medtronic, Stryker, BD (Becton, Dickinson and Company), Biom'up Innovative Surgery, Johnson & Johnson Services, Inc., CryoLife, Inc., Hemostatis LLC.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos